首页 | 本学科首页   官方微博 | 高级检索  
检索        

重组人CD40配体对卵巢癌SKOV3细胞生长特性的影响
引用本文:刘艳,施勤.重组人CD40配体对卵巢癌SKOV3细胞生长特性的影响[J].中国病理生理杂志,2006,22(10):2002-2006.
作者姓名:刘艳  施勤
作者单位:1苏州大学附二院妇产科, 江苏 苏州 215004;2苏州大学生命科学学院生物技术研究所, 江苏 苏州 215007
基金项目:苏州大学校科研和教改项目
摘    要:目的: 观察重组人CD40配体(rhCD40L)对卵巢癌细胞株SKOV3增殖、表面抗原变化、细胞周期、凋亡相关基因及肿瘤坏死因子受体相关因子( TRAFs)的影响。 方法: 在体外将SKOV3细胞与不同浓度的rhCD40L作用72 h后MTT法测定细胞增殖;直接免疫荧光标记流式细胞术测定细胞表面抗原及TRAFs变化,RT-PCR法测定凋亡相关基因c-myc、bcl-2、bcl-xl的表达程度,并用Annexin V和PI双标记测定细胞凋亡水平。 结果: rhCD40L在100 μg/L的低剂量时即可抑制SKOV3细胞增殖(0.65±0.10 vs 0.81±0.05),其作用随着rhCD40L浓度的增加而加强,10 mg/L时抑制率达(0.13±0.12 vs 0.83±0.15,P<0.01),呈明显的浓度相关性,并使细胞分裂阻滞于G1期;rhCD40L可上调SKOV3细胞CD95的表达(42.4% vs 59.2%, P<0.05),下调抗凋亡基因bcl-2和bcl-xl的表达,促进其凋亡;SKOV3细胞高表达TRAF2(81.3%±9.2%)、TRAF5(47.2%±7.2%)和TRAF6(44.5%±6.3%),rhCD40L可显着下调TRAF2(50.4%±5.3%,P<0.05)、TRAF5(7.2%±2.1%,P<0.01)和TRAF6(5.1%±1.1%,P<0.01)表达,而上调TRAF3(25.2%±6.2% vs 68.8%±5.3%,P<0.01)表达,对TRAF1(4.3%±1.2% vs 5.1%±1.4%)和4(7.4%±1.2% vs 8.1%±1.4%)的表达则无作用。 结论: rhCD40L通过下调bcl-2和bcl-xl基因表达,并改变细胞内TRAFs表达,使SKOV3细胞的增殖受阻滞于G1期,并促进其凋亡。

关 键 词:卵巢肿瘤  CD40配体  受体  肿瘤坏死因子  细胞增殖  细胞周期  SKOV3细胞  
文章编号:1000-4718(2006)10-2002-05
收稿时间:2005-12-27
修稿时间:2005-12-272006-04-26

Effects of recombinant human CD40 ligand on biological behavior of ovarian cancer SKOV3 cells in vitro
LIU Yan,SHI Qin.Effects of recombinant human CD40 ligand on biological behavior of ovarian cancer SKOV3 cells in vitro[J].Chinese Journal of Pathophysiology,2006,22(10):2002-2006.
Authors:LIU Yan  SHI Qin
Institution:1Department of Obstetrics and Gynecology, The Second Affiliated Hospital of Soochow University, Suzhou 215004, China;2 Suzhou University, Suzhou 215007, China
Abstract:AIM: To investigate the effect of recombinated human CD40 ligand (rhCD40L) on the biological behavior of ovarian cancer SKOV3 cell line in vitro.METHODS: After the SKOV3 cells were incubated with different concentrations of rhCD40L for various times, the cell proliferation was determined by MTT assay.The expression of the co-stimulatory molecules or adhesion molecules on SKOV3 cells and the changes of tumor necrosis factor receptor associated factor (TRAFs) inside the cells were measured by flow cytometry and direct immunofluorescence.Annexin V and PI dual color label assay were used to detect cell apoptosis or death in culture contained with rhCD40L.RT-PCR assay was employed to determine the change of apoptosis related gene c-myc, bcl-2 and bcl-xl expression in SKOV3 cells.RESULTS: rhCD40L inhibited proliferation of SKOV3 cells at concentration of 100 μg/L (0.65±0.10 vs 0.81±0.05) and reached a peak at concentration of 10 mg/L (0.13±0.12 vs 0.83±0.15, P<0.01).The inhibitory effects showed a dose dependent manner.Cell cycle analysis showed that cell division was blocked in G1 phase.Increasing proportion of apoptosis of SKOV3 cells was related to up-regulation of CD95 expression (42.4% vs 59.2%, P<0.05) and down-regulation of anti-apoptosis genes such as bcl-2 and bcl-xl expressions after incubation with rhCD40L.TRAF 2, 5 and 6 expressed highly in SKOV3 cells.The expression of TRAF 2 (81.3%±9.2% vs 50.4%±5.3%,P<0.05), TRAF5 (47.2%±7.2% vs 7.2%±2.1%, P<0.01) and TRAF6 (44.5%±6.3% vs 5.1%±1.1%, P<0.01) was down-regulated and expression of TRAF 3 (25.2%±6.2% vs 68.8%±5.3%, P<0.01) was up-regulated after co-culture with rhCD40L, but there was no effects found on the expression of TRAF 1 (4.3%±1.2% vs 5.1%±1.4%) and TRAF4 (7.4%±1.2% vs 8.1%±1.4%).CONCLUSION: By down-regulating expression of bcl-2, bcl-xl and changing expression profile of TRAF, rhCD40L inhibits the growth of SKOV3 cells by blocking the cell cycle progress in G1 and promotes the cells to apoptosis.
Keywords:Ovarian neoplasms  CD40 ligand  Receptors  tumor necrosis factor  Cell proliferation  Cell cycle  SKOV3 cells
本文献已被 CNKI 万方数据 等数据库收录!
点击此处可从《中国病理生理杂志》浏览原始摘要信息
点击此处可从《中国病理生理杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号